Proinflammatory fecal mRNA and childhood bacterial enteric infections

Gut Microbes

Volumn 1, Issue 4, 2010, Pages 209-212

  Bennett Jr , William E ^a   González Rivera, Rosbel ^b   Puente, Bao N ^a   Shaikh, Nurmohammad ^a   Stevens, Harold J ^a   Mooney, Jody C ^c   Klein, Eileen J ^c,d   Denno, Donna M ^c,d   Draghi II , Andrew ^e   Sylvester, Francisco A ^e   Tarr, Phillip I ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^c SEATTLE CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Campylobacter; E. coli O157:H7; Enzyme immunoassay; Infectious colitis; mRNA; Salmonella; Shigella; Stool

Indexed keywords

EID: 84872321304     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gmic.1.4.13004     Document Type: Article

References (15)

1. Mohr S, Liew CC. The peripheral-blood transcriptome: new insights into disease and risk assessment. Trends Mol Med 2007; 13:422-32.
2. Roos PH, Golka K, Hengstler JG. Predictive biomarkers and signatures in urinary bladder cancer. Curr Opin Mol Ther 2008; 10:243-50.
3. Farber CR, Lusis AJ. Integrating global gene expression analysis and genetics. Adv Genet 2008; 60:571-601.
4. Kang S, Denman SE, Morrison M, Yu Z, McSweeney CS. An efficient RNA extraction method for estimating gut microbial diversity by polymerase chain reaction. Curr Microbiol 2009; 58:464-71.
5. Bennett WE Jr, Gonzalez-Rivera R, Shaikh N, Magrini V, Boykin M, Warner BB et al. A method for isolating and analyzing human mRNA from newborn stool. J Immunol Methods 2009.
6. Azim T, Halder RC, Sarker MS, Ahmed S, Hamadani J, Chowdhury A et al. Cytokines in the stools of children with complicated shigellosis. Clin Diagn Lab Immunol 1995; 2:492-5.
7. de Silva DG, Mendis LN, Sheron N, Alexander GJ, Candy DC, Chart H et al. Concentrations of interleukin 6 and tumour necrosis factor in serum and stools of children with Shigella dysenteriae 1 infection. Gut 1993; 34:194-8.
8. Greenberg DE, Jiang ZD, Steffen R, Verenker MP, DuPont HL. Markers of inflammation in bacterial diarrhea among travelers, with a focus on enteroaggregative Escherichia coli pathogenicity. J Infect Dis 2002; 185:944-9.
9. Kaiser T, Langhorst J, Wittkowski H, Becker K, Friedrich AW, Rueffer A et al. Faecal S100A12 as a noninvasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome. Gut 2007; 56:1706-13.
10. Vidal K, Serrant P, Schlosser B, van den Broek P, Lorget F, Donnet-Hughes A. Osteoprotegerin production by human intestinal epithelial cells: a potential regulator of mucosal immune responses. Am J Physiol Gastrointest Liver Physiol 2004; 287:836-44.
11. Nicholls S, Stephens S, Braegger CP, Walker-Smith JA, MacDonald TT. Cytokines in stools of children with inflammatory bowel disease or infective diarrhoea. J Clin Pathol 1993; 46:757-60.
12. Finkbeiner SR, Allred AF, Tarr PI, Klein EJ, Kirkwood CD, Wang D. Metagenomic analysis of human diarrhea: viral detection and discovery. PLoS Pathog 2008; 4:1000011.
13. Cornick NA, Jelacic S, Ciol MA, Tarr PI. Escherichia coli O157:H7 infections: discordance between filterable fecal shiga toxin and disease outcome. J Infect Dis 2002; 186:57-63.
14. Jones J, Loftus EV Jr, Panaccione R, Chen LS, Peterson S, McConnell J et al. Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease. Clin Gastroenterol Hepatol 2008; 6:1218-24.
15. Peterson CG, Sangfelt P, Wagner M, Hansson T, Lettesjo H, Carlson M. Fecal levels of leukocyte markers reflect disease activity in patients with ulcerative colitis. Scand J Clin Lab Invest 2007; 67:810-20.